The_DT
Epstein-Barr_JJ
virus_NN
oncogene_NN
product_NN
latent_JJ
membrane_NN
protein_NN
1_CD
engages_VBZ
the_DT
tumor_NN
necrosis_NN
factor_NN
receptor-associated_JJ
death_NN
domain_NN
protein_NN
to_TO
mediate_VB
B_NN
lymphocyte_NN
growth_NN
transformation_NN
and_CC
activate_VB
NF-kappaB_NN
._.

The_DT
Epstein-Barr_JJ
virus_NN
latent_JJ
membrane_NN
protein_NN
1_CD
-LRB-_-LRB-
LMP1_NN
-RRB-_-RRB-
is_VBZ
essential_JJ
for_IN
the_DT
transformation_NN
of_IN
B_NN
lymphocytes_NNS
into_IN
lymphoblastoid_JJ
cell_NN
lines_NNS
._.

Previous_JJ
data_NNS
are_VBP
consistent_JJ
with_IN
a_DT
model_NN
that_IN
LMP1_NN
is_VBZ
a_DT
constitutively_RB
activated_VBN
receptor_NN
that_WDT
transduces_VBZ
signals_NNS
for_IN
transformation_NN
through_IN
its_PRP$
carboxyl-terminal_JJ
cytoplasmic_JJ
tail_NN
._.

One_CD
transformation_NN
effector_NN
site_NN
-LRB-_-LRB-
TES1_NN
-RRB-_-RRB-
,_,
located_JJ
within_IN
the_DT
membrane_NN
proximal_JJ
45_CD
residues_NNS
of_IN
the_DT
cytoplasmic_JJ
tail_NN
,_,
constitutively_RB
engages_VBZ
tumor_NN
necrosis_NN
factor_NN
receptor-associated_JJ
factors_NNS
._.

Signals_NNS
from_IN
TES1_NN
are_VBP
sufficient_JJ
to_TO
drive_VB
initial_JJ
proliferation_NN
of_IN
infected_JJ
resting_VBG
B_NN
lymphocytes_NNS
,_,
but_CC
most_JJS
lymphoblastoid_JJ
cells_NNS
infected_VBN
with_IN
a_DT
virus_NN
that_WDT
does_VBZ
not_RB
express_VB
the_DT
155_CD
residues_NNS
beyond_IN
TES1_NN
fail_VBP
to_TO
grow_VB
as_IN
long-term_JJ
cell_NN
lines_NNS
._.

We_PRP
now_RB
find_VBP
that_IN
mutating_VBG
two_CD
tyrosines_NNS
to_TO
an_DT
isoleucine_NN
at_IN
the_DT
carboxyl_NN
end_NN
of_IN
the_DT
cytoplasmic_JJ
tail_NN
cripples_VBZ
the_DT
ability_NN
of_IN
EBV_NN
to_TO
cause_VB
lymphoblastoid_JJ
cell_NN
outgrowth_NN
,_,
thereby_RB
marking_VBG
a_DT
second_JJ
transformation_NN
effector_NN
site_NN
,_,
TES2_NN
._.

A_DT
yeast_NN
two-hybrid_JJ
screen_NN
identified_VBD
TES2_NN
interacting_VBG
proteins_NNS
,_,
including_VBG
the_DT
tumor_NN
necrosis_NN
factor_NN
receptor-associated_JJ
death_NN
domain_NN
protein_NN
-LRB-_-LRB-
TRADD_NN
-RRB-_-RRB-
._.

TRADD_NN
was_VBD
the_DT
only_JJ
protein_NN
that_WDT
interacted_VBD
with_IN
wild-type_JJ
TES2_NN
and_CC
not_RB
with_IN
isoleucine-mutated_JJ
TES2_NN
._.

TRADD_NN
associated_VBN
with_IN
wild-type_JJ
LMP1_NN
but_CC
not_RB
with_IN
isoleucine-mutated_JJ
LMP1_NN
in_IN
mammalian_JJ
cells_NNS
,_,
and_CC
TRADD_NN
constitutively_RB
associated_VBN
with_IN
LMP1_NN
in_IN
EBV-transformed_JJ
cells_NNS
._.

In_IN
transfection_NN
assays_NNS
,_,
TRADD_NN
and_CC
TES2_NN
synergistically_RB
mediated_VBD
high-level_JJ
NF-kappaB_NN
activation_NN
._.

These_DT
results_NNS
indicate_VBP
that_IN
LMP1_NN
appropriates_VBZ
TRADD_NN
to_TO
enable_VB
efficient_JJ
long-term_JJ
lymphoblastoid_JJ
cell_NN
outgrowth_NN
._.

High-level_JJ
NF-kappaB_NN
activation_NN
also_RB
appears_VBZ
to_TO
be_VB
a_DT
critical_JJ
component_NN
of_IN
long-term_JJ
outgrowth_NN
._.

